product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Aurora A/AIK Antibody
catalog :
3092S
quantity :
100 ul
price :
235 USD
clonality :
polyclonal
host :
rabbit
reactivity :
human
application :
western blot
citations: 4
Published Application/Species/DilutionReference
  • western blot; human; 1:1000; fig 5-s1
Wang W, Wu T, Kirschner M. The master cell cycle regulator APC-Cdc20 regulates ciliary length and disassembly of the primary cilium. elife. 2014;3:e03083 pubmed publisher
  • western blot; human; 1:1000; fig 1
Clijsters L, Wolthuis R. PIP-box-mediated degradation prohibits re-accumulation of Cdc6 during S phase. J Cell Sci. 2014;127:1336-45 pubmed publisher
  • western blot; human
Lin Y, Richards F, Krippendorff B, Bramhall J, Harrington J, Bapiro T, et al. Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells. Br J Cancer. 2012;107:1692-701 pubmed publisher
Polacchini A, Albani C, Baj G, Colliva A, Carpinelli P, Tongiorgi E. Combined cisplatin and aurora inhibitor treatment increase neuroblastoma cell death but surviving cells overproduce BDNF. Biol Open. 2016;5:899-907 pubmed publisher
product information
SKU :
3092S
Product-Name :
Aurora A/AIK Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, Mk
Applications :
Western blot
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
48
Host :
Rabbit
Target :
Aurora A
Primary-Protein :
AurA
Alt-Names :
AIK,ARK-1,ARK1,AURA,AURKA,AURORA2,Aurora A,Aurora kinase A,Aurora-related kinase 1,Aurora/IPL1-related kinase 1,BTAK,Breast tumor-amplified kinase,IPL1-related kinase,MGC34538,STK15,STK6,STK7,Serine/threonine-protein kinase 15,Serine/threonine-protein kinase 6,Serine/threonine-protein kinase aurora-A,aurora/IPL1-like kinase,breast-tumor-amplified kinase,hARK1,serine/threonine kinase 6,serine/threonine protein kinase 15
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.